Clinical trials recruiting for Clear Cell Renal Cell Cancer (ccRCC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| GI-101 | 1 |
| GI-101A | 1 |
| Lenvatinib | 1 |
| Pembrolizumab (KEYTRUDA®) | 1 |
| [177Lu]Lu-DPI-4452 | 1 |
| [68Ga]Ga-DPI-4452 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 1 |
| North Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Related conditions
Trials recruiting for Clear Cell Renal Cell Cancer (ccRCC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Clear Cell Renal Cell Cancer (ccRCC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.